Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Deok-Hwan Yang, MD PhD, Jae-Sook Ahn, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Young Rok Do, PhDMD, Sang Yun Song, MD PhD, Ga-Young Song, Hyeong Jong Kim, MD, Theresa Kim

Blood (2019) 134 (Supplement_1): 2329.

https://doi.org/10.1182/blood-2019-126533

Published: 2019

Journal Articles

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL)

Luis E Malpica Castillo, MD, Camila Peña, MD, Christine Rojas, MD, Pilar León, MD, Brady E. Beltrán, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Mimsy Quinones, MD, Sally Rose Paredes, MD, Henry Idrobo, MD, Ivan Perdomo, MD, Virginia Abello, MD, Lorena Fiad, MD, Victoria Otero, MD, Marialejandra Torres Viera, MD, Luis Villela M, Eduardo Sotomayor, MD, Jorge J Castillo, MD, Juan Carlos Ramos, MD BS

Blood (2019) 134 (Supplement_1): 4045.

https://doi.org/10.1182/blood-2019-122976

Published: 2019

Journal Articles

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Nora St Victor Dély, MD, Ofelia A. Alvarez, MD, Vanessa J Dor, MD, Emmeline Lerebours, MD

Blood (2019) 134 (Supplement_1): 2306.

https://doi.org/10.1182/blood-2019-124105

Published: 2019

Journal Articles

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Ofelia A. Alvarez, MD, Tally Hustace, ARNP, Mimose Voltaire, RN, Rodrigueson Rizil, Ulrick Liberus, Rony Saint Fleur, MD

Blood (2018) 132 (Supplement 1): 3670.

https://doi.org/10.1182/blood-2018-99-115384

Published: 2018

Journal Articles

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Rose Mintor, Steve Morisseau, Romain Jean Louis, Marlene Damas Borgella, Christophe Milien, Marc Julmisse, Joseph Ubaike, Chris Wong, Michelle Niescierenko, Natasha Archer, MD

Blood (2017) 130 (Supplement 1): 3353.

https://doi.org/10.1182/blood.V130.Suppl_1.3353.3353

Published: 2017

Journal Articles

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Luis E Malpica Castillo, MD, Agustin Pimentel, MD, Isildinha M Reis, PhD, Eduardo Gotuzzo, MD, Lazaros J. Lekakis, MD, Krishna Komanduri, MD, Thomas J. Harrington, MD, Glen N. Barber, PhD, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 373.

https://doi.org/10.1182/blood.V130.Suppl_1.373.373

Published: 2017

Journal Articles

Hydroxyurea to Treat Pediatric Sickle Cell Disease in Haiti - a Preliminary Report

Nicholas McGregor, MD, Emmeline Lerebours, MD, Prasad Bodas, MD

Blood (2016) 128 (22): 1313.

https://doi.org/10.1182/blood.V128.22.1313.1313

Published: 2016

Journal Articles

Prevalence of Sickle Cell Disease, Hemoglobin S, and Hemoglobin C Among Haitian Newborns: Feasibility of Newborn Screening for Hemoglobinopathies in Haiti

Genevieve Arty, MD, Rotz Seth, MD, Prasad Bodas, MD, Lucia De Zen, MD, Francesco Angelo Zanolli, MD, Roberto Dall'Amico, MD

Blood (2012) 120 (21): 4235.

https://doi.org/10.1182/blood.V120.21.4235.4235

Published: 2012

Journal Articles

The Quest for Hb Questembert: A Challenging Case of An Unstable Hb Variant

Kavita Natarajan, Niren Patel, MBBS, Lina Zhuang, MD, Harris Carmichael, Elizabeth Manaloor, MD, Abdullah Kutlar, MD, Ferdane Kutlar, MD

Blood (2010) 116 (21): 4814.

https://doi.org/10.1182/blood.V116.21.4814.4814

Published: 2010

Journal Articles

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Franck Morschhauser, MD, John P. Leonard, MD, Luis Fayad, MD, Bertrand Coiffier, MD, STephen J. Schuster, MD, Martin J.S. Dyer, MD, Marie-Odile Petillon, MD, Morton Coleman, MD, Amina Bahkti, Heather Horne, Li Xu, MD, Nick Teoh, PhD, William A. Wegener, MD, David M. Goldenberg, MD

Blood (2006) 108 (11): 2719.

https://doi.org/10.1182/blood.V108.11.2719.2719

Published: 2006

Journal Articles

Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

Mariana Mesel-Lemoine, Mustapha Cherai, Sabine Le Gouvello, Maude Guillot, Virginie Leclercq, David Klatzmann, Véronique Thomas-Vaslin, François M. Lemoine

Blood (2006) 107 (1): 381–388.

https://doi.org/10.1182/blood-2005-07-2658

Published: 2006

Journal Articles

The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F)VIII Gene (F8) Mutations in African-American Hemophilia A Patients.

Tom E. Howard, MD, PhD, Deepa K. Machiah, BS, Kevin R. Viel, PhD, Cynthia Channel, BS, Afshin Ameri, MD, Rathi V. Iyer, MD, Ray G. Watts, MD, Charles Lutcher, MD, Joanna Davis, MD, Thomas C. Abshire, MD, Laura Almasy, PhD

Blood (2005) 106 (11): 3207.

https://doi.org/10.1182/blood.V106.11.3207.3207

Published: 2005

Journal Articles

African-Americans Express Multiple Haplotypic Forms of the Wildtype Factor VIII (FVIII) Protein: A Possible Role for Pharmacogenetics in FVIII Inhibitor Development?.

Tom Howard, M.D., Ph.D., Deepa M. Machiah, Ph.D., Thuy T. Tran, Kevin R. Viel, B.S., Cynthia Channell, B.S., Jose Manuel Soria, Ph.D., Afshin Ameri, M.D., Rathi V. Iyer, M.D., Cara Brown, B.S., R.N., Christopher Doering, Ph.D., Laura Almasy, Ph.D., Ray Watts, M.D., Joanna Davis, M.D., Thomas C. Abshire, M.D.

Blood (2004) 104 (11): 384.

https://doi.org/10.1182/blood.V104.11.384.384

Published: 2004

NARROW

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL)

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Hydroxyurea to Treat Pediatric Sickle Cell Disease in Haiti - a Preliminary Report

Prevalence of Sickle Cell Disease, Hemoglobin S, and Hemoglobin C Among Haitian Newborns: Feasibility of Newborn Screening for Hemoglobinopathies in Haiti

The Quest for Hb Questembert: A Challenging Case of An Unstable Hb Variant

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F)VIII Gene (F8) Mutations in African-American Hemophilia A Patients.

African-Americans Express Multiple Haplotypic Forms of the Wildtype Factor VIII (FVIII) Protein: A Possible Role for Pharmacogenetics in FVIII Inhibitor Development?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only